By staff writers

May 11, 2017 -- Eckert & Ziegler Radiopharma has announced plans to expand the production capacity of its manufacturing line for its GalliaPharm germanium-68/gallium-68 generator.

The move comes on the heels of the approval of two tumor diagnostic agents, Netspot in the U.S. and SomaKit TOC in the European Union, which is prompting increased demand for pharmaceutical generators, the company said

Copyright © 2017

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking